| CLEARMIND MEDICINE |
| Kanada |
| Gesundheit |
| CA1850535016 / A41YK5 |
| CWY (Frankfurt) / CMND (NASDAQ) |
| FRA:CWY, ETR:CWY, CWY:GR, NASDAQ:CMND |
| - |
| https://www.clearmindmedi.. |
|
Clearmind Medicine Inc. is a clinical-stage psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to address underserved health issues. Its primary efforts center on treatments f..
>Volltext.. |
| 1.95 Mio. EUR |
| -7 Mio. EUR |
| - |
| -6.74 Mio. EUR |
| -5.75 Mio. EUR |
| -20.91 EUR |
| 0.01 Mio. EUR |
| 8.02 Mio. EUR |
| -4.85 Mio. EUR |
| 3.56 |
| - |
| -33.91% |
| - |
| - |
| - |
| - |
| CLEARMIND |
| 05.04.26 |
|